ProCE Banner Activity

Adjuvant Therapy for Patients With HR+/HER2- EBC at High Risk of Recurrence: Downloadable Slides

Slideset Download

Download this slideset to review the latest data on adjuvant treatment for patients with HR+/HER2- early breast cancer.

Released: May 12, 2021

Share

Faculty

Stephen R. D. Johnston

Stephen R. D. Johnston, MA, FRCP, PhD

Professor of Breast Cancer Medicine
Breast Unit
Department of Medicine
Royal Marsden Hospital
London, United Kingdom

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from

Lilly

Faculty Disclosure

Primary Author

Stephen R. D. Johnston, MA, FRCP, PhD

Professor of Breast Cancer Medicine
Breast Unit
Department of Medicine
Royal Marsden Hospital
London, United Kingdom